• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Recent Advances in the Application of Methyl 5-amino-2-(trifluoromethyl)benzoate (CAS: 575474-23-6) in Chemical Biology and Pharmaceutical Research

Methyl 5-amino-2-(trifluoromethyl)benzoate (CAS: 575474-23-6) has emerged as a key intermediate in pharmaceutical synthesis and chemical biology research. Recent studies have highlighted its versatility as a building block for the development of novel bioactive compounds, particularly in the areas of kinase inhibitors and antimicrobial agents. The trifluoromethyl group at the 2-position and the amino functionality at the 5-position provide unique electronic and steric properties that enable diverse chemical modifications, making this compound particularly valuable for structure-activity relationship (SAR) studies.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's utility in developing selective JAK3 inhibitors. Researchers utilized Methyl 5-amino-2-(trifluoromethyl)benzoate as a core scaffold, achieving significant improvements in both potency (IC50 values in the low nanomolar range) and selectivity profiles compared to previous generation inhibitors. The trifluoromethyl group was found to play a crucial role in binding interactions within the JAK3 ATP-binding pocket, as confirmed by X-ray crystallography studies.

In antimicrobial research, a team from the University of Tokyo reported in Bioorganic & Medicinal Chemistry Letters (2024) on novel quinolone derivatives synthesized using 575474-23-6 as a starting material. These compounds exhibited potent activity against drug-resistant Gram-positive pathogens, with MIC values as low as 0.25 μg/mL against MRSA strains. The researchers attributed this enhanced activity to the improved membrane permeability conferred by the trifluoromethyl group and the ability of the amino group to form additional hydrogen bonds with bacterial targets.

The compound has also shown promise in PET tracer development. A recent study in the Journal of Nuclear Medicine (2024) described the synthesis of fluorine-18 labeled analogs of Methyl 5-amino-2-(trifluoromethyl)benzoate for imaging σ-1 receptors in neurological disorders. The radiolabeled compounds demonstrated excellent brain penetration and specific binding in preclinical models, suggesting potential applications in Alzheimer's disease imaging.

From a synthetic chemistry perspective, several innovative methodologies have been developed for the efficient production and derivatization of 575474-23-6. A 2023 Organic Process Research & Development paper detailed a continuous flow process that improved yield by 35% while reducing hazardous waste generation compared to traditional batch methods. This advancement addresses growing concerns about sustainable pharmaceutical manufacturing practices.

Looking forward, the unique properties of Methyl 5-amino-2-(trifluoromethyl)benzoate continue to inspire novel applications. Current research directions include its incorporation into PROTAC molecules for targeted protein degradation and as a key component in covalent inhibitor design. The compound's versatility ensures it will remain an important tool in medicinal chemistry and chemical biology research for years to come.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)